Chimeric transcriptional control units for improved liver-specific transgene expression.

Area of Science:

• Gene Therapy
• Molecular Biology
• Hepatology

Background:

• Effective gene therapy requires precise control of gene expression in target cells.
• Liver-specific promoters are crucial for hepatocyte-directed gene delivery.
• Existing liver-specific elements lack systematic evaluation for optimal combinations.

Purpose of the Study:

• To systematically compare different combinations of liver-specific promoters and enhancers.
• To identify the most effective transcriptional control unit for hepatocyte-directed gene expression.
• To optimize gene delivery strategies for liver gene therapy.

Main Methods:

• Constructed 25 synthetic transcriptional units combining four liver-specific core promoters with hepatocyte-specific enhancers.
• Evaluated transcriptional activity of these units in cell culture and in vivo mouse liver models.
• Performed comparative analysis of promoter-enhancer configurations.

Main Results:

• Identified a superior transcriptional control unit for liver-specific gene expression.
• The combination of alcohol dehydrogenase 6 (ADH6) basal promoter with two tandem apolipoprotein E enhancer copies demonstrated highest activity.
• This specific construct showed significant transcriptional activity in hepatocytes.

Conclusions:

• The ADH6 promoter linked to tandem apolipoprotein E enhancers is the optimal choice for liver-specific transgene expression.
• This finding advances the development of efficient gene therapy vectors targeting the liver.
• Provides a validated tool for enhancing therapeutic gene delivery to hepatocytes.